By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 16_suppl (2024): 9529-9529
0
0
Immuno-Oncology and Technologypp.100712, (2024)
WOS
0
0
Paul Nathan
Consultant Medical Oncologist
The Mount Vernon Cancer Centre
Follow
Claim
分享
Follow
Claim
分享
基本信息
views: 175
Career TrajectoryBio
Dr Nathan has a specialist interest in the treatment of renal cell carcinoma (kidney cancer) and melanoma (both uveal and cutaneous). He also has an interest in Merkel Cell Carcinoma.
He is the first author of the UK guidelines for the systemic treatment of renal cell carcinoma, a member of the National Cancer Research Institute groups for both renal carcinoma and melanoma and is secretary of the UK Melanoma Study Group. He also is a member of the panel currently reviewing the national melanoma guidelines.
He is the first author of the UK guidelines for the systemic treatment of renal cell carcinoma, a member of the National Cancer Research Institute groups for both renal carcinoma and melanoma and is secretary of the UK Melanoma Study Group. He also is a member of the panel currently reviewing the national melanoma guidelines.
Research Interests
Author Statistics
#Papers: 7
#Citation: 2
H-Index: 1
G-Index: 1
Sociability: 5
Diversity: 1
Activity: 1
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn